Covered recipient · General Payments record
JIEQI LIU
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2022–2024
$1,313.86
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $746.12 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $139.84 | 2 |
| GlaxoSmithKline, LLC. | $54.71 | 3 |
| PFIZER INC. | $51.33 | 3 |
| Blueprint Medicines Corporation | $41.39 | 2 |
| Lilly USA, LLC | $34.88 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.67 | 2 |
| Janssen Biotech, Inc. | $29.05 | 2 |
| Mirati Therapeutics, Inc. | $25.03 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.55 | 1 |
| TAIHO ONCOLOGY, INC. | $23.90 | 1 |
| Alnylam Pharmaceuticals Inc. | $22.40 | 1 |
| Apellis Pharmaceuticals, Inc. | $21.20 | 1 |
| ARRAY BIOPHARMA INC | $21.01 | 1 |
| Merck Sharp & Dohme Corporation | $20.41 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.00 | 1 |
| BeiGene USA, Inc. | $18.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.00 | 1 |
| Daiichi Sankyo Inc. | $17.89 | 1 |
| Astellas Pharma US Inc | $17.50 | 1 |
| Octapharma USA, Inc. | $17.22 | 1 |
| Genentech USA, Inc. | $17.18 | 1 |
| Celgene Corporation | $16.59 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.45 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.99 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.80 | 1 |
| Incyte Corporation | $13.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.